In the year 2015, the GCC Countries Anti-Viral drugs market is expected
to increase during the forecast period. Anti-Viral drugs are the drugs
used to treat viral infections which can range from infections like flu
to AIDS (Acquired Immuno Deficiency Syndrome). Just like common cold
which is also caused by virus, most viral diseases are extremely
difficult to cure and what the anti-viral drugs mostly do is slow down
the reproduction of virus which in some cases enables immune system to
eliminate the virus (as in case of flu) while slowing down the disease
progression in other cases (as in case of AIDS).

The need of anti-viral drugs for patient's lifetime in case of diseases
like HIV/AIDS along with well-established supply chain that facilitates
easy procurement are driving the growth of this market. While the
increasing use of generics along with lack of incentivization and lack
of curative anti-viral drugs for indications like HIV/AIDS are hindering
the growth of this market.

Lack of broad spectrum anti-viral drugs is currently the huge unmet need
in this market and presents a great opportunity to companies. While the
negative impact of viral vaccines on the growth of anti-viral drugs
market and increasing focus on prevention rather than cure of viral
diseases are currently the challenges faced by this market.